WeightNameValue
1000 Titel
  • Insulin and IGF-1 receptors regulate FoxO-mediated signaling in muscle proteostasis
1000 Autor/in
  1. O’Neill, Brian T. |
  2. Lee, Kevin Y. |
  3. Klaus, Katherine |
  4. Softic, Samir |
  5. Krumpoch, Megan T. |
  6. Fentz, Joachim |
  7. Stanford, Kristin I. |
  8. Robinson, Matthew M. |
  9. Cai, Weikang |
  10. Kleinridders, Andre |
  11. Pereira, Renata O. |
  12. Hirshman, Michael F. |
  13. Abel, E. Dale |
  14. Accili, Domenico |
  15. Goodyear, Laurie J. |
  16. Nair, K. Sreekumaran |
  17. Kahn, C. Ronald |
1000 Erscheinungsjahr 2016
1000 LeibnizOpen
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2016-08-15
1000 Erschienen in
1000 Quellenangabe
  • 126(9): 3433-3446
1000 FRL-Sammlung
1000 Copyrightjahr
  • 2016
1000 Verlagsversion
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004956/ |
  • https://doi.org/10.1172/JCI86522 |
1000 Ergänzendes Material
  • https://www.jci.org/articles/view/86522#sd |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Diabetes strongly impacts protein metabolism, particularly in skeletal muscle. Insulin and IGF-1 enhance muscle protein synthesis through their receptors, but the relative roles of each in muscle proteostasis have not been fully elucidated. Using mice with muscle-specific deletion of the insulin receptor (M-IR-/- mice), the IGF-1 receptor (M-IGF1R-/- mice), or both (MIGIRKO mice), we assessed the relative contributions of IR and IGF1R signaling to muscle proteostasis. In differentiated muscle, IR expression predominated over IGF1R expression, and correspondingly, M-IR-/- mice displayed a moderate reduction in muscle mass whereas M-IGF1R-/- mice did not. However, these receptors serve complementary roles, such that double-knockout MIGIRKO mice displayed a marked reduction in muscle mass that was linked to increases in proteasomal and autophagy-lysosomal degradation, accompanied by a high-protein-turnover state. Combined muscle-specific deletion of FoxO1, FoxO3, and FoxO4 in MIGIRKO mice reversed increased autophagy and completely rescued muscle mass without changing proteasomal activity. These data indicate that signaling via IR is more important than IGF1R in controlling proteostasis in differentiated muscle. Nonetheless, the overlap of IR and IGF1R signaling is critical to the regulation of muscle protein turnover, and this regulation depends on suppression of FoxO-regulated, autophagy-mediated protein degradation.
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/creator/T_KAmU5laWxsLCBCcmlhbiBULg==|https://frl.publisso.de/adhoc/creator/TGVlLCBLZXZpbiBZLg==|https://frl.publisso.de/adhoc/creator/S2xhdXMsIEthdGhlcmluZQ==|https://frl.publisso.de/adhoc/creator/U29mdGljLCBTYW1pcg==|https://frl.publisso.de/adhoc/creator/S3J1bXBvY2gsIE1lZ2FuIFQu|https://frl.publisso.de/adhoc/creator/RmVudHosIEpvYWNoaW0=|https://frl.publisso.de/adhoc/creator/U3RhbmZvcmQsIEtyaXN0aW4gSS4=|https://frl.publisso.de/adhoc/creator/Um9iaW5zb24sIE1hdHRoZXcgTS4=|https://frl.publisso.de/adhoc/creator/Q2FpLCBXZWlrYW5n|https://frl.publisso.de/adhoc/creator/S2xlaW5yaWRkZXJzLCBBbmRyZQ==|https://frl.publisso.de/adhoc/creator/UGVyZWlyYSwgUmVuYXRhIE8u|https://frl.publisso.de/adhoc/creator/SGlyc2htYW4sIE1pY2hhZWwgRi4=|https://frl.publisso.de/adhoc/creator/QWJlbCwgRS4gRGFsZQ==|https://frl.publisso.de/adhoc/creator/QWNjaWxpLCBEb21lbmljbw==|https://frl.publisso.de/adhoc/creator/R29vZHllYXIsIExhdXJpZSBKLg==|https://frl.publisso.de/adhoc/creator/TmFpciwgSy4gU3JlZWt1bWFyYW4=|https://frl.publisso.de/adhoc/creator/S2FobiwgQy4gUm9uYWxk
1000 Label
1000 Förderer
  1. National Institutes of Health (NIH) |
  2. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the NIH |
  3. National Center for Advancing Translational Sciences of the NIH |
  4. German Research Foundation (DFG) |
  5. Joslin Diabetes Research Center core facility |
1000 Fördernummer
  1. R01 DK031036; R01 AR42238; R01 DK41973; U24 DK100469
  2. K08 DK100543; U24 DK100469; K01 DK105109
  3. UL1 TR000135
  4. Kl2399-1/1
  5. P30 DK36836
1000 Förderprogramm
  1. -
  2. K08 training award; Mayo Clinic Metabolomics Resource Core grant; K01 award
  3. Mayo Clinic Clinical and Translational Science Awards grant
  4. -
  5. -
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer National Institutes of Health (NIH) |
    1000 Förderprogramm -
    1000 Fördernummer R01 DK031036; R01 AR42238; R01 DK41973; U24 DK100469
  2. 1000 joinedFunding-child
    1000 Förderer National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the NIH |
    1000 Förderprogramm K08 training award; Mayo Clinic Metabolomics Resource Core grant; K01 award
    1000 Fördernummer K08 DK100543; U24 DK100469; K01 DK105109
  3. 1000 joinedFunding-child
    1000 Förderer National Center for Advancing Translational Sciences of the NIH |
    1000 Förderprogramm Mayo Clinic Clinical and Translational Science Awards grant
    1000 Fördernummer UL1 TR000135
  4. 1000 joinedFunding-child
    1000 Förderer German Research Foundation (DFG) |
    1000 Förderprogramm -
    1000 Fördernummer Kl2399-1/1
  5. 1000 joinedFunding-child
    1000 Förderer Joslin Diabetes Research Center core facility |
    1000 Förderprogramm -
    1000 Fördernummer P30 DK36836
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6403640.rdf
1000 Erstellt am 2017-08-02T13:52:33.788+0200
1000 Erstellt von 122
1000 beschreibt frl:6403640
1000 Bearbeitet von 288
1000 Zuletzt bearbeitet 2021-03-31T09:35:10.856+0200
1000 Objekt bearb. Wed Mar 31 09:35:10 CEST 2021
1000 Vgl. frl:6403640
1000 Oai Id
  1. oai:frl.publisso.de:frl:6403640 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source